REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$71.55
0.00%
(0.00) 1D
Sep 3, 4:56:00 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$72.51
High
R$72.51
Low
R$71.40
Mkt. cap
86.84B
Avg. vol.
806.00
Volume
1.74K
52-wk high
R$73.13
52-wk low
R$49.06
Shares outstanding
101.14M
No. of employees
15K
Open
R$72.51
High
R$72.51
Low
R$71.40
Mkt. cap
86.84B
Avg. vol.
806.00
Volume
1.74K
52-wk high
R$73.13
52-wk low
R$49.06
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
AD HOC NEWS
·
8 hours ago
Regeneron stock steadies after strong Q2 figures and pipeline focus
Kalkine Media
·
14 hours ago
REGENERON PHARMACEUTICALS Director Kathryn Guarini to Sell $340K in Shares (NASDAQ: REGN)
PR Newswire
·
14 hours ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
Simply Wall Street
·
1 day ago
Why Did Regeneron Pharmaceuticals (REGN) Climb After Its Latest Update?
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com